Contact
Please use this form to send email to PR contact of this press release:
Biomed Industries Announces Phase 3 Trials of NA-931 Targeting Durable Weight Loss & Lean-Mass Preservation at JPM Week
TO:
Michael Willis
Biomed Industries, Inc.
+ +1 800-824-5135